Predicting risk of secondary progression in multiple sclerosis: A nomogram
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Predicting risk of secondary progression in multiple sclerosis: A nomogram
Authors
Keywords
-
Journal
Multiple Sclerosis Journal
Volume -, Issue -, Pages 135245851878366
Publisher
SAGE Publications
Online
2018-06-18
DOI
10.1177/1352458518783667
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of function
- (2017) Daniel Ontaneda et al. LANCET
- Long-term evolution of multiple sclerosis disability in the treatment era
- (2016) et al. ANNALS OF NEUROLOGY
- Defining secondary progressive multiple sclerosis
- (2016) Johannes Lorscheider et al. BRAIN
- Clinical course of multiple sclerosis: A nationwide cohort study
- (2016) Ali Manouchehrinia et al. Multiple Sclerosis Journal
- Importance of early treatment initiation in the clinical course of multiple sclerosis
- (2016) Andrius Kavaliunas et al. Multiple Sclerosis Journal
- Clinical course of multiple sclerosis: A nationwide cohort study
- (2016) Ali Manouchehrinia et al. Multiple Sclerosis Journal
- Importance of early treatment initiation in the clinical course of multiple sclerosis
- (2016) Andrius Kavaliunas et al. Multiple Sclerosis Journal
- The Swedish MS registry - clinical support tool and scientific resource
- (2015) J. Hillert et al. ACTA NEUROLOGICA SCANDINAVICA
- Beta-interferon exposure and onset of secondary progressive multiple sclerosis
- (2015) T. Zhang et al. EUROPEAN JOURNAL OF NEUROLOGY
- A much-needed focus on progression in multiple sclerosis
- (2015) Alan J Thompson LANCET NEUROLOGY
- Development and validation of nomograms to provide individualised predictions of seizure outcomes after epilepsy surgery: a retrospective analysis
- (2015) Lara Jehi et al. LANCET NEUROLOGY
- Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial
- (2014) Peter A Calabresi et al. LANCET NEUROLOGY
- Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study
- (2013) Ali Manouchehrinia et al. BRAIN
- Brain atrophy and lesion load predict long term disability in multiple sclerosis
- (2013) Veronica Popescu et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Neurofilaments as biomarkers in multiple sclerosis
- (2012) Charlotte E Teunissen et al. Multiple Sclerosis Journal
- External validation of nomogram for the prediction of recurrence after curative resection in early gastric cancer
- (2011) J. H. Kim et al. ANNALS OF ONCOLOGY
- The natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disability
- (2010) Antonio Scalfari et al. BRAIN
- The natural history of secondary progressive multiple sclerosis
- (2010) M. Koch et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Emerging effects of comorbidities on multiple sclerosis
- (2010) Ruth Ann Marrie et al. LANCET NEUROLOGY
- New perspectives in the natural history of multiple sclerosis
- (2010) H. Tremlett et al. NEUROLOGY
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Review: Treatment of early multiple sclerosis: the value of treatment initiation after a first clinical episode
- (2009) DS Goodin et al. Multiple Sclerosis Journal
- Impact of multiple sclerosis relapses on progression diminishes with time
- (2009) H. Tremlett et al. NEUROLOGY
- Natural history of multiple sclerosis in a population-based cohort
- (2008) M. Debouverie et al. EUROPEAN JOURNAL OF NEUROLOGY
- Factors associated with the risk of secondary progression in multiple sclerosis
- (2008) M Koch et al. Multiple Sclerosis Journal
- Natural history of secondary-progressive multiple sclerosis
- (2008) Helen Tremlett et al. Multiple Sclerosis Journal
- Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3
- (2007) Thierry Gorlia et al. LANCET ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started